Carbone, David P.
- Ohio State University · Internal Medicine (NIH department code)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #30,931
- Sustained Excellence
- R01 Holder
- Long-Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2006 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2023 award categories
- Internal Medicine
NIH Funding · FY2023
Linked Award Amount
$380.5K
Full award amounts, FY2023
Award Records
1
Records listing this PI
Award-Linked Rank
#30,931
By linked amount among FY2023 PIs
Earliest Year Loaded
2006
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Carbone, David P. as a PI. Multi-PI records show the full award amount for context.
- 5R01CA248741-03R01Contact PITargeting immunosuppressive adenosine in patients with metastatic non-small cell lung cancerOhio State University · Internal Medicine (NIH department code)$380.5Kaward amount
Award organization
Organizations that administered FY2023 awards listing Carbone, David P. as a PI.
FY2023 award administered by Ohio State University (OH).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2006First NIH AwardOhio State University
- 2006$500K Cumulative Funding
- 2006$1M Cumulative Funding
- 2006$2M Cumulative Funding
- 2006Entered Top 50% NationallyRanked #929
- 2006Entered Top 25% NationallyRanked #929
- 2006Entered Top 10% NationallyRanked #929
- 2006Entered Top 5% NationallyRanked #929
- 2007$5M Cumulative Funding
- 2008$10M Cumulative Funding
- 2010R01 Grant Holder